首页 | 本学科首页   官方微博 | 高级检索  
     

论基本药物的可获得性和可及性障碍
引用本文:刘宝,武瑞雪,叶露. 论基本药物的可获得性和可及性障碍[J]. 中国药房, 2007, 18(14): 1041-1043
作者姓名:刘宝  武瑞雪  叶露
作者单位:复旦大学公共卫生学院卫生经济学教研室,上海市,200032
摘    要:目的:考察基本药物的可获得性和可及性障碍。方法:以基本药物的可获得性和可及性为切入点,系统阐述在基本药物生产、流通和使用等各个环节中存在的问题。结果:目前我国整条基本药物供需链系统地表现出短缺问题,其中既有基于供应角度的可获得性障碍问题,又有基于需方角度的可及性障碍问题。结论:完善国家基本药物制度、构建基本药物体系,要有产业联动的统筹观。

关 键 词:基本药物  短缺  可获得性  可及性
文章编号:1001-0408(2007)14-1041-03
收稿时间:2007-03-17
修稿时间:2007-04-17

Barrier of Availability and Accessibility to Essential Drugs
LIU Bao,WU Ruixue,YE Lu. Barrier of Availability and Accessibility to Essential Drugs[J]. China Pharmacy, 2007, 18(14): 1041-1043
Authors:LIU Bao  WU Ruixue  YE Lu
Affiliation:Dept .of Health Economics, School of Public Health, Fudan University, Shanghai 200032, China
Abstract:OBJECTIVE:To study the barrier of the availability of and accessibility to essential drugs.METHODS:The conceptual framework of the demand-supply chain of essential drugs was explained.RESULTS:The problems faced by the overall demand-supply chain were the shortage of essential drugs,including the barrier of availability on the supply side,as well as the barrier of accessibility to essential medicines on the demand side.CONCLUSION:Systematic view on the industry of essential drugs is a key in the evolvement of national essential medicine policy and construction of essential medicine system.
Keywords:Essential medicines  Shortage  Availability  Accessibility
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号